Delivery Order SPE2DR25D1017-SPE2DR26F9APX
- Not listed
- The Defense Logistics Agency awarded a $8,708.90 delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injectors, with an ultimate completion date of September 17, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. The pharmaceutical product will be sourced from the vendor's Conshohocken, Pennsylvania facility, where...
- The Defense Logistics Agency awarded a $18,469.99 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of ENBREL 50 mg/ml SureClick auto-injectors, with an ultimate completion date of December 9, 2025. This non-competitive delivery order award represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical, a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through December 2026. The...
- The Defense Logistics Agency has awarded a delivery order valued at $9,427.34 to AmerisourceBergen Drug Corp for the supply of ENBREL 50 MG/ML SureClick auto-injector medication. The contract, awarded on September 5, 2025, with an ultimate completion date of September 8, 2025, operates under firm fixed pricing with no set-aside designation. Performance will occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under the company's broader Indefinite...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $26,090.03 for ENBREL 50 mg/ml SureClick auto-injectors, with an ultimate completion date of April 25, 2025. This firm fixed price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 through December 2026. The pharmaceutical will be...
- The Defense Logistics Agency awarded a delivery order valued at $9,253.56 to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injectors, with a completion date of July 15, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $25,207.11 delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/ml SureClick auto-injectors, with an ultimate completion date of June 26, 2025. This non-set-aside, competitively awarded contract employs firm fixed price terms and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $16,080.68 delivery order to AmerisourceBergen Drug Corp for ENBREL 50 MG/ML SureClick auto-injectors, with completion scheduled for November 4, 2025. This non-competitive delivery order employs firm fixed price pricing and will be performed at the contractor's Conshohocken, Pennsylvania headquarters. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a $10,820.21 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/mL SureClick auto-injectors, with a completion deadline of September 30, 2025. This non-competed delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The company, headquartered in Conshohocken, Pennsylvania, serves as...
- The Defense Logistics Agency awarded a $105,657.59 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ENBREL 50 MG/ML SureClick auto-injectors, with an ultimate completion date of October 28, 2025. This non-set-aside, competitively awarded contract represents a single delivery order fulfillment under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of...
- The Defense Logistics Agency awarded a $106,169.26 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injectors, with an ultimate completion date of December 8, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The place of...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9APXDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,478.93 to AmerisourceBergen Drug Corp for ENBREL 50 mg/ml SureClick auto-injectors, with an ultimate completion date of December 2, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp serves as a critical vendor within the federal medical supply chain, providing pharmaceutical products and medical supplies to support military and veteran healthcare systems. The SPE2DX contract functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply an extensive range of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This specific delivery order for ENBREL, a medication used to treat rheumatoid arthritis and other inflammatory conditions, demonstrates the company's role in fulfilling specialized pharmaceutical procurement needs within the defense health system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.5k | 11/30/25 |